Taken together, our data reveal novel Egr-1 signaling that mediates the NF-&#954;B and AP-1 pathways to orchestrate PM-induced pulmonary inflammation and mucus hyperproduction, suggesting that Egr-1 inhibition could be an effective therapeutic approach for airway disorders or disease exacerbations induced by airborne particulate pollution.
C0032285
Pneumonia